TOMM20 and metabolic dysfunction-associated steatohepatitis: According to the above mentioned NASH study, enhanced mitophagic level is characterized by elevated LC3/TOMM20 and decreased p62/TOMM20 ratios as the result of palmitic acid administered to mouse primary hepatocytes [33].